Literature DB >> 3767967

Oversulfated chondroitin sulfate proteoglycan in cultured human peritoneal macrophages.

S O Kolset.   

Abstract

Human peritoneal macrophages were cultured in vitro and labeled with [35S]-sulfate. Both on day 1 and day 6 in culture the cells were found to synthesize exclusively chondroitin sulfate proteoglycan, the main part (70%) being associated with the medium after a 20 hour pulse. The glycosaminoglycan chains were found to be oversulfated both after 1 and 6 days in culture, due to the presence of disulfated disaccharide units.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3767967     DOI： 10.1016/s0006-291x(86)80001-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  5 in total

1.  Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins.

Authors:  B Halvorsen; U K Aas; M A Kulseth; C A Drevon; E N Christiansen; S O Kolset
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

2.  Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells.

Authors:  R L Stevens; C C Fox; L M Lichtenstein; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Human macrophages cultured on agar but not agarose resemble mast cells.

Authors:  A S Kirshenbaum; J P Goff; D D Metcalfe
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

4.  Proteoglycan synthesis in human erythroleukaemia (HEL) cells.

Authors:  B P Schick; S Senkowski-Richardson
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

Review 5.  Serglycin: at the crossroad of inflammation and malignancy.

Authors:  Angeliki Korpetinou; Spyros S Skandalis; Vassiliki T Labropoulou; Gianna Smirlaki; Argyrios Noulas; Nikos K Karamanos; Achilleas D Theocharis
Journal:  Front Oncol       Date:  2014-01-13       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.